Keyword: Food and Drug Administration (FDA)

News

Carbogen Amcis to Take Over High-Containment Facility

08.08.2014 - Carbogen Amcis, Swiss-based pharmaceutical process development and active pharmaceutical ingredient (API) manufacturer, has announced plans to take over operations of a high...

News

Ebola Patients Reported Treated with Biotech Firm’s Drug

05.08.2014 - Shares of Tekmira Pharmaceuticals, one of a few companies to have developed Ebola treatments advanced enough to be tested on people, soared in early August 4 trading, but later...

Plant Construction & Process Technology

Preparing for Tomorrow’s Pharmaceutical Challenges

08.06.2014 - The pharmerging markets will still be extending their progress by 10 to 13%, as population increases and rising incomes contribute to dramatically higher use of medicines. Improved...

Markets & Companies

Opportunities Through Biotechnology

06.06.2014 - Latin America continues to be an area of rising investment for the pharmaceutical industry, with Brazil and Mexico leading the way. Not only is Latin America an attractive target...

News

FDA Seen as Foot Dragging on Sunscreen Ingredient Approval

04.06.2014 - US dermatologists are expressing increased concern over what they see as foot dragging by the Food and Drug Administration on approving new chemicals for sunscreens. During a...

Plant Construction & Process Technology

Good Manufacturing Practices

04.06.2014 - Regulatory Requirements - Good Manufacturing Practices (GMPs) represent the minimum requirements that must be satisfied when producing pharmaceuticals for human or veterinary use...

News

US Court Dismisses Teva Case to Block Generic Copaxone

16.05.2014 - Shortly before expiration of the patent on the multiple sclerosis treatment Copaxone, a US district court has dismissed a case by Teva Pharmaceutical Industries, subsidiary of the...

Plant Construction & Process Technology

Preparing for Tomorrow’s Pharmaceutical Challenges

09.05.2014 - New legislation, expiring patents and increasing healthcare costs call for decisive changes in the global pharmaceutical industry. New markets for specialty medicines...